Charmacy Pharmaceutical Co Ltd
HKEX:2289
Cash Flow Statement
Cash Flow Statement
Charmacy Pharmaceutical Co Ltd
Dec-2015 | Jun-2016 | Dec-2016 | Jun-2017 | Dec-2017 | Jun-2018 | Dec-2018 | Jun-2019 | Dec-2019 | Jun-2020 | Dec-2020 | Jun-2021 | Dec-2021 | Jun-2022 | Dec-2022 | Jun-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow | |||||||||||||||||
Net Income |
42
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Depreciation & Amortization |
9
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Other Non-Cash Items |
3
|
(7)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Cash Taxes Paid |
0
|
0
|
(32)
|
(52)
|
(37)
|
(31)
|
(41)
|
(51)
|
(39)
|
(28)
|
(27)
|
(37)
|
(37)
|
(31)
|
(36)
|
(41)
|
|
Cash Interest Paid |
24
|
21
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Change in Working Capital |
140
|
41
|
(102)
|
(141)
|
(33)
|
(37)
|
49
|
84
|
4
|
(205)
|
131
|
241
|
(20)
|
59
|
44
|
(153)
|
|
Cash from Operating Activities |
194
N/A
|
47
-76%
|
(102)
N/A
|
(130)
-28%
|
(33)
+75%
|
(37)
-13%
|
49
N/A
|
84
+70%
|
4
-95%
|
(205)
N/A
|
131
N/A
|
241
+84%
|
(20)
N/A
|
59
N/A
|
44
-25%
|
(153)
N/A
|
|
Investing Cash Flow | |||||||||||||||||
Capital Expenditures |
(30)
|
(42)
|
(20)
|
(22)
|
(126)
|
(159)
|
(98)
|
(76)
|
(74)
|
(75)
|
(52)
|
(46)
|
(25)
|
(6)
|
(9)
|
(36)
|
|
Other Items |
(138)
|
(40)
|
0
|
(28)
|
2
|
0
|
0
|
0
|
0
|
(1)
|
(3)
|
(2)
|
1
|
1
|
80
|
160
|
|
Cash from Investing Activities |
(168)
N/A
|
(82)
+51%
|
(20)
+76%
|
(50)
-154%
|
(123)
-148%
|
(159)
-29%
|
(98)
+39%
|
(76)
+22%
|
(74)
+3%
|
(76)
-3%
|
(55)
+28%
|
(48)
+13%
|
(24)
+49%
|
(5)
+80%
|
72
N/A
|
124
+73%
|
|
Financing Cash Flow | |||||||||||||||||
Net Issuance of Common Stock |
188
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Net Issuance of Debt |
(11)
|
(10)
|
129
|
244
|
243
|
154
|
21
|
68
|
210
|
277
|
65
|
(51)
|
137
|
(4)
|
(245)
|
38
|
|
Cash Paid for Dividends |
(46)
|
(16)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Other |
(24)
|
(21)
|
(49)
|
(102)
|
(129)
|
(7)
|
8
|
(88)
|
(156)
|
30
|
(68)
|
(168)
|
(63)
|
(17)
|
54
|
17
|
|
Cash from Financing Activities |
108
N/A
|
141
+31%
|
80
-44%
|
142
+78%
|
114
-20%
|
147
+29%
|
29
-80%
|
(20)
N/A
|
54
N/A
|
307
+467%
|
(3)
N/A
|
(219)
-8 086%
|
74
N/A
|
(21)
N/A
|
(191)
-805%
|
54
N/A
|
|
Change in Cash | |||||||||||||||||
Effect of Foreign Exchange Rates |
0
|
0
|
6
|
4
|
(2)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Net Change in Cash |
133
N/A
|
106
-20%
|
(36)
N/A
|
(34)
+6%
|
(44)
-32%
|
(50)
-11%
|
(19)
+61%
|
(12)
+35%
|
(16)
-25%
|
26
N/A
|
74
+180%
|
(26)
N/A
|
30
N/A
|
33
+8%
|
(75)
N/A
|
25
N/A
|
|
Free Cash Flow | |||||||||||||||||
Free Cash Flow |
163
N/A
|
5
-97%
|
(121)
N/A
|
(152)
-26%
|
(159)
-4%
|
(196)
-24%
|
(49)
+75%
|
7
N/A
|
(70)
N/A
|
(280)
-301%
|
79
N/A
|
195
+146%
|
(45)
N/A
|
53
N/A
|
35
-33%
|
(190)
N/A
|